X4 Pharmaceuticals announced Monday morning that the FDA approved its daily pill for WHIM syndrome — an ultra-rare immune disease named after its symptoms.
READ MOREMerck KGaA is allocating over €300 million ($321.8 million) to build a new research building at its headquarters in Darmstadt, Germany to study technologies for its life science business.
READ MORE